Intrauterine Contraceptive Devices Market to Reach USD 6.7 Billion by 2034

Pune, India, November 11, 2025 - The global Intrauterine Contraceptive Devices (IUD) Market is expected to rise from USD 4.3 billion in 2024 to USD 6.7 billion by 2034, registering a CAGR of 4.5 %, according to Exactitude Consultancy. Growing awareness of long-acting reversible contraception (LARC), rising government investment in family-planning programs, and product innovation in hormonal and non-hormonal IUDs are propelling market growth worldwide.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/50026

Key Takeaways
• Market Size (2024): USD 4.3 Billion
• Forecast (2034): USD 6.7 Billion
• CAGR (2025 - 2034): 4.5 %
• Leading Companies: Bayer AG, CooperSurgical Inc., Pfizer Inc., AbbVie Inc., Medtronic plc, DKT International, Meril Life Sciences, Allergan plc, Eurogine S.L., and SMB Corporation of India.
• Core Products: Hormonal IUDs (Levonorgestrel-Releasing) and Copper IUDs (Non-Hormonal).

Market Story
Intrauterine contraceptive devices (IUDs) have emerged as one of the most effective and cost-efficient forms of birth control. Their ability to provide long-term reversible protection-lasting 3 to 10 years-makes them an essential component of global family-planning initiatives.

Rising healthcare access in developing countries and shifting consumer preferences toward low-maintenance contraceptive options are boosting demand. At the same time, advances in hormone-release mechanisms and biocompatible copper designs are enhancing safety and comfort.

Market Segmentation
• By Type: Hormonal IUD (Levonorgestrel IUS) | Copper IUD (Non-Hormonal)

• By Age Group: Below 25 Years | 25-34 Years | 35 Years and Above

• By End User: Hospitals | Gynecology Clinics | Community Health Centers | Family-Planning Organizations

• By Region:
o North America: Largest market; strong presence of FDA-approved IUD brands like Mirena and Paragard.
o Europe: Expanding adoption through public-health programs and government reimbursements.
o Asia Pacific: Fastest-growing region driven by population control initiatives in India and China.
o Latin America & MEA: Increased access via NGO-led women's-health campaigns.

Explore Full Report here: https://exactitudeconsultancy.com/reports/50026/intrauterine-contraceptive-devices-market

Recent Developments
• 2025: Bayer AG launched an upgraded low-dose levonorgestrel IUD offering five-year contraceptive efficacy with reduced side effects.
• 2024: CooperSurgical introduced a next-gen frameless IUD designed for greater comfort and biocompatibility.
• 2023: Pfizer partnered with public-health agencies to expand IUD availability in rural markets through subsidized programs.
• 2022: DKT International rolled out a multi-country campaign to raise awareness about LARC methods among young women.

Expert Quote
"The IUD market is at the intersection of innovation and public health. Smarter hormonal delivery systems and broader awareness campaigns are making long-acting contraception both accessible and empowering for women worldwide," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.

Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=50026

Market Drivers
1. Government-Led Family-Planning Initiatives promoting LARC methods.
2. Rising Awareness of Women's Health and Reproductive Rights.
3. Technological Advancements in hormone-release control and biodegradable materials.
4. Growing Preference for Reversible, Low-Maintenance Contraception.
Forecast Outlook
From 2025 to 2034, manufacturers will focus on miniaturized IUD designs, sustainable materials, and AI-assisted clinical placement tools. Asia Pacific will emerge as a major growth hub through government-supported fertility-control initiatives and private-sector collaboration.

Conclusion
The Intrauterine Contraceptive Devices Market is expanding rapidly as technological innovation, public-health investment, and social awareness align to offer safe, effective, and accessible birth-control solutions to women worldwide.

This report is also available in the following languages : Japanese (子宮内避妊器具市場), Korean (자궁 내 피임 장치 시장), Chinese (宫内节育器市场), French (Marché des dispositifs contraceptifs intra-utérins), German (Markt für intrauterine Verhütungsmittel), and Italian (Mercato dei dispositivi contraccettivi intrauterini), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/50026/intrauterine-contraceptive-devices-market#request-a-sample

Related Reports
Non Hormonal Contraceptives Market
https://exactitudeconsultancy.com/reports/72879/non-hormonal-contraceptives-market

Birth Control Wearable Market
https://exactitudeconsultancy.com/reports/53842/global-birth-control-wearable-market

Twin Transfusion Syndrome Treatment Market
https://exactitudeconsultancy.com/reports/51154/twin-transfusion-syndrome-treatment-market

U.S. Veterinary Artificial Insemination Market
https://exactitudeconsultancy.com/reports/50578/u-s-veterinary-artificial-insemination-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.